HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stent procedure put to the test for failing hearts
Disease control Not yet recruitingThis study aims to see if a common artery-opening procedure (using a stent) combined with standard heart failure medications works better than the medications alone for people with a weak heart pump caused by clogged heart arteries. It will enroll about 650 adults who have heart …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Novartis tests new heart pill in early safety trial
Disease control Not yet recruitingThis early-stage study aims to check if a new drug called HJB647 is safe for people with chronic heart failure. About 12 participants will receive either the drug or a placebo for three days while doctors monitor for side effects. The main goal is to understand how the body proce…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New 'Breathing Pacemaker' aims to ease heart failure burden
Disease control Not yet recruitingThis study is testing a new implanted device called the VisONE System. It aims to see if gently stimulating the diaphragm (the main breathing muscle) in sync with the heartbeat can improve heart function, walking ability, and quality of life for people with a specific type of hea…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: VisCardia Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
App aims to keep heart failure patients out of hospital
Disease control Not yet recruitingThis study is testing whether a digital care platform can help people with a weakened heart pump (heart failure) stay healthier after leaving the hospital. About 774 patients will either use an app to report daily symptoms and vital signs, which helps doctors adjust medications, …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Chang sheng Ma • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Heart failure breakthrough? major trial tests if catheter procedures beat pills for AFib
Disease control Not yet recruitingThis trial aims to find the best way to manage atrial fibrillation (AFib) in people who also have heart failure. It will compare two main approaches: using catheter-based procedures to restore normal heart rhythm versus using medications and devices to control the heart rate. The…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE4 • Sponsor: University of British Columbia • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New heart failure device trial aims to reduce hospital visits and deaths
Disease control Not yet recruitingThis study is testing a medical device designed to lower dangerously high blood pressure in the lungs of people with heart failure. Researchers will compare the device procedure to a placebo procedure in 750 participants who are already on the best available heart medications. Th…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Pulnovo Medical, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC